How we can shrink our pill box To view or add a comment, sign in Millions of Americans living with diabetes will soon have access to affordable insulin, thanks to Civica upcoming launch
Sleep apnea TRIUMPH-1 nested basket trial This is one of the headline additions from the new data
People who were hospitalized due to gastroparesis or bowel obstruction, who were diagnosed with NAION vision loss, ileus or pancreatitis, or who experienced pulmonary aspiration during surgery or while under anesthesia after using Ozempic, Wegovy, Saxenda, Victoza, or Mounjaro may be eligible for compensation
Jennifer Hardy Jun 25, 202511 min read The New GLP-1 Diet Blueprint: 8 Expert-Approved Guidelines You Need to Know MAY 30, 2025 New GLP-1 diet and lifestyle guidelines are poised to help first-time users navigate the real work that comes after the

Means lower Emerging observational studies and small interventional trials suggest that GLP-1 RAs may be used in patients with advanced CKD with preserved glucose-lowering efficacy and a relatively low intrinsic risk of hypoglycemia compared with insulin and sulfonylureas ( Semaglutide has recently received expanded regulatory approval for use in patients with T2DM and CKD, reflecting growing confidence in its renal safety profile and potential kidney-protective benefits ( In Saudi Arabia, T2DM prevalence is among the highest worldwide and is accompanied by high rates of obesity, cardiovascular disease, and CKD ( Therefore, this multicenter retrospective study aimed to evaluate the real-world safety and effectiveness of semaglutide in patients with ESRD receiving care at Saudi tertiary healthcare centers, with a focus on glycemic outcomes, body weight changes, cardiovascular events, renal safety, and treatment tolerability